Global Blood Purification Membrane Market Growth 2026-2032
The global Blood Purification Membrane market size is predicted to grow from US$ 998 million in 2025 to US$ 1563 million in 2032; it is expected to grow at a CAGR of 6.7% from 2026 to 2032.
Blood Purification Membrane refers to the functional semipermeable membrane used as the core separation medium in extracorporeal blood purification, primarily in hollow-fiber dialyzers and related blood purification filters. Its principal function is to achieve selective transport or removal of uremic solutes, excess water and other target substances through diffusion, convection and, for certain membrane materials, adsorption, while controlling the loss of essential macromolecules such as albumin. Commercial Blood Purification Membrane products are differentiated by polymer chemistry, hollow-fiber structure, pore-size distribution, membrane thickness, surface characteristics, permeability, molecular-weight cut-off, biocompatibility and sterilization condition. Main material platforms include polysulfone, polyethersulfone, cellulose triacetate, PMMA, PAN/AN69, PEPA and EVAL, while product performance ranges from conventional low- and medium-flux membranes to high-flux, medium cut-off and high cut-off designs. This study focuses on Blood Purification Membrane products used in hospital hemodialysis units, independent dialysis centers and home dialysis environments.
Key Findings
Synthetic membranes remain the core platform for mainstream blood purification membranes
High-flux and sharper cut-off designs are advancing product differentiation
Middle-molecule clearance and albumin retention define next-generation performance priorities
Institutional dialysis settings remain the principal downstream demand base
Material chemistry and hollow-fiber engineering shape competitive differentiation
Market Trends
The Blood Purification Membrane market is moving from basic solute-removal capability toward more precisely engineered separation performance. High-flux membranes remain an important commercial platform, while medium cut-off, sharp cut-off and other enhanced-permeability technologies are extending clearance toward larger middle molecules without proportionally increasing albumin loss. At the same time, membrane development is becoming increasingly multidimensional: manufacturers are optimizing polymer formulation, asymmetric pore architecture, fiber wall thickness, hydrophilicity, surface modification and blood compatibility rather than relying solely on nominal flux classification. Polysulfone and polyethersulfone continue to support broad product portfolios, while CTA, PMMA, PEPA and other differentiated materials maintain specific positions based on biocompatibility, adsorption characteristics or transport profiles. Product development is therefore increasingly centered on balancing clearance efficiency, selectivity, albumin retention, hemocompatibility and treatment stability, with membrane engineering becoming a major determinant of clinical positioning and product differentiation.
Market Dynamics
Drivers
Demand for Blood Purification Membrane is fundamentally supported by the recurring nature of maintenance hemodialysis and the continuous requirement for disposable dialyzers and filtration components. Beyond patient volume, the market is increasingly influenced by higher expectations for dialysis adequacy and broader toxin-removal performance. Clinical product development has moved beyond efficient removal of small solutes toward improved removal of middle and larger-middle molecules, creating demand for more precisely controlled membrane pore structures and permeability profiles. Expansion of high-flux dialysis, hemodiafiltration and other enhanced blood purification approaches also raises the technical requirements placed on membrane materials. At the manufacturing level, continuous improvements in hollow-fiber spinning, polymer blending and membrane surface engineering enable suppliers to improve performance while maintaining consistency at commercial production scale, supporting replacement and upgrading of established membrane platforms.
Restraints
Blood Purification Membrane manufacturing has relatively high technical and quality-control barriers because changes in polymer composition, spinning conditions, pore-size distribution or surface characteristics can affect clearance, albumin loss, blood compatibility and filtration stability. Manufacturers therefore need to maintain tight process control from polymer preparation and hollow-fiber spinning through module assembly and sterilization. More advanced permeability is not automatically equivalent to better overall performance, as higher transport capacity must be balanced against unwanted macromolecule loss and treatment safety. Product development also faces qualification and regulatory requirements associated with medical devices and blood-contacting materials, which can lengthen commercialization cycles. In addition, established dialysis systems and clinical operating protocols create switching costs, meaning new membrane technologies generally require both measurable performance differentiation and reliable manufacturing consistency before achieving broad adoption.
Opportunities
The principal opportunity lies in the transition from conventional flux-based differentiation toward membranes engineered around defined molecular-removal windows. Medium cut-off, sharp cut-off, super high-flux and related technologies demonstrate increasing industry attention to removal of larger middle molecules while preserving clinically important proteins. This creates opportunities for membrane suppliers capable of controlling pore distribution more precisely and integrating selective transport with improved hemocompatibility. Specialty membrane materials also retain opportunity where adsorption, biocompatibility or unique polymer structures provide functional differentiation beyond standard polysulfone platforms. Another opportunity is vertical integration: companies with internal capabilities in polymer formulation, hollow-fiber spinning, membrane modification and dialyzer assembly can shorten development cycles and more closely coordinate membrane performance with finished-device design. Chinese manufacturers with integrated membrane-spinning and assembly capabilities may benefit from continued localization of high-performance dialysis consumables.
Challenges
The major long-term challenge is converting incremental membrane improvements into clinically meaningful and commercially defensible differentiation. Blood Purification Membrane performance is determined by multiple interacting parameters, and improvements in clearance must be balanced against albumin retention, blood compatibility, mechanical stability and reproducibility. Competition is also moving toward increasingly sophisticated proprietary fiber structures and membrane formulations, raising R&D and process-development requirements. At the same time, dialysis consumables are used repeatedly and at large volume, making manufacturing yield, quality consistency and cost control important alongside clinical performance. New membrane technologies must therefore demonstrate not only differentiated separation characteristics but also scalable production, sterilization compatibility and stable performance across treatment conditions. The need to satisfy both clinical and economic requirements can slow the adoption of technologies whose performance gains are insufficiently differentiated from established high-flux products.
Industry Chain Analysis
The upstream value base of the Blood Purification Membrane industry consists primarily of medical-grade polymer resins and cellulose derivatives, membrane-forming solvents and additives, hydrophilic modifiers, potting and housing materials, together with precision hollow-fiber spinning, extrusion and inspection equipment. Polymer purity, molecular-weight distribution, formulation stability and raw-material consistency have direct influence on membrane morphology and production yield. In the midstream, value creation is concentrated in polymer formulation, spinning solution preparation, hollow-fiber extrusion, phase separation, pore-structure control, surface modification, washing, drying or wet preservation, module assembly and sterilization. These steps determine permeability, selectivity, blood compatibility and manufacturing consistency. Downstream, membranes are integrated into dialyzers and related blood purification filters and ultimately consumed through hospital dialysis units, independent dialysis centers and home dialysis channels. Compared with standardized structural components, a greater proportion of technological differentiation is concentrated in membrane formulation, fiber formation and pore-control capabilities; manufacturers that integrate membrane spinning with dialyzer assembly can more directly optimize membrane properties, housing design and overall clearance performance as a single system.
Segment Insights
By membrane material, synthetic polymer membranes constitute the main technology platform, with polysulfone and polyethersulfone supporting a broad range of commercial hemodialysis products because they can be engineered across different permeability and clearance levels. The market nevertheless remains technologically diversified: cellulose triacetate emphasizes a differentiated blood-contact material route, PMMA combines filtration with characteristic protein adsorption, and PEPA uses a polymer-alloy structure to achieve differentiated transport and endotoxin-retention characteristics. These specialty materials therefore compete less through simple material substitution and more through specific performance profiles.
By permeability and cut-off characteristics, the competitive focus is progressively shifting toward high-flux and more selectively engineered membrane structures. Low- and medium-flux products continue to address established treatment requirements, while high-flux products provide stronger small- and middle-molecule clearance. Medium cut-off, high cut-off and newer sharp cut-off designs extend the technical frontier by narrowing the balance between enhanced removal of larger molecules and retention of albumin. Sterilization method and dry-versus-wet product configuration represent additional product-engineering dimensions because they affect manufacturing processes, storage, handling and membrane conditioning. These segmentation dimensions increasingly interact rather than operate independently, making membrane design a multi-parameter optimization problem.
Downstream Market Opportunities
Hospital hemodialysis units and independent dialysis centers remain the principal downstream environments for Blood Purification Membrane consumption because recurring treatments generate continuous demand for single-use dialyzers and related filtration products. In these institutional settings, purchasing decisions increasingly balance clearance performance, treatment compatibility, operating convenience, supply reliability and overall consumable economics. Home dialysis represents a smaller but strategically relevant application direction, where standardized preparation, reliable membrane performance and user-friendly consumable design become particularly important. Across downstream settings, the opportunity is gradually shifting from supplying a generic filtration medium toward matching membrane characteristics to specific therapy objectives, including conventional hemodialysis, high-flux treatment and broader middle-molecule removal. Suppliers capable of linking membrane performance with complete dialyzer design and treatment protocols are therefore positioned to capture more value than suppliers competing primarily on basic membrane capacity.
Regional Insights
Regional development of the Blood Purification Membrane industry reflects differences in dialysis infrastructure, local manufacturing capability and membrane technology accumulation. Japan has a particularly diversified technology base across polysulfone, polyethersulfone, CTA, PMMA and PEPA membrane platforms, supported by multiple established manufacturers with proprietary membrane technologies. Europe combines large integrated dialysis-system suppliers with specialized membrane and filtration capabilities, while the North American market remains an important commercialization environment for advanced high-flux and expanded-hemodialysis technologies. China is increasingly characterized by localization of hollow-fiber membrane spinning and dialyzer assembly, with domestic suppliers developing integrated production capabilities rather than relying solely on imported membrane components. As a result, regional competition is becoming less dependent on simple production capacity and more dependent on membrane formulation, manufacturing consistency, clinical positioning and integration with local dialysis delivery systems.
Competitive Landscape Analysis
Competition in Blood Purification Membrane is technology-led and closely linked to vertical integration in the dialysis consumables industry. Fresenius Medical Care, Asahi Kasei Medical, Nikkiso, Nipro, Toray, B. Braun, Vantive and SB-KAWASUMI participate through differentiated dialyzer and membrane platforms, while MEDICA contributes specialized hollow-fiber membrane capabilities and WEGO represents an increasingly integrated Chinese supply model. The competitive basis is not limited to membrane material choice: companies differentiate through polymer formulation, proprietary hollow-fiber structures, permeability profiles, surface engineering, adsorption characteristics, albumin retention, sterilization design and integration between membrane and dialyzer architecture. Established suppliers benefit from accumulated membrane-processing expertise, validated manufacturing processes and broad dialysis-product portfolios, while newer product development is concentrating on high-flux, MCO, sharp cut-off and other advanced separation profiles. Chinese suppliers are strengthening internal membrane-spinning and assembly capabilities, increasing competition in localized supply and manufacturing integration. The market therefore exhibits a combination of established global dialysis platforms, specialized membrane technologies and emerging vertically integrated regional manufacturers rather than a single standardized technology route.
Report Scope
LP Information, Inc. (LPI) ' newest research report, the “Blood Purification Membrane Industry Forecast” looks at past sales and reviews total world Blood Purification Membrane sales in 2025, providing a comprehensive analysis by region and market sector of projected Blood Purification Membrane sales for 2026 through 2032. With Blood Purification Membrane sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Blood Purification Membrane industry.
This Insight Report provides a comprehensive analysis of the global Blood Purification Membrane landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Blood Purification Membrane portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Blood Purification Membrane market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Blood Purification Membrane and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Blood Purification Membrane.
This report presents a comprehensive overview, market shares, and growth opportunities of Blood Purification Membrane market by product type, application, key manufacturers and key regions and countries.
Market Segmentation
Blood Purification Membrane refers to the functional semipermeable membrane used as the core separation medium in extracorporeal blood purification, primarily in hollow-fiber dialyzers and related blood purification filters. Its principal function is to achieve selective transport or removal of uremic solutes, excess water and other target substances through diffusion, convection and, for certain membrane materials, adsorption, while controlling the loss of essential macromolecules such as albumin. Commercial Blood Purification Membrane products are differentiated by polymer chemistry, hollow-fiber structure, pore-size distribution, membrane thickness, surface characteristics, permeability, molecular-weight cut-off, biocompatibility and sterilization condition. Main material platforms include polysulfone, polyethersulfone, cellulose triacetate, PMMA, PAN/AN69, PEPA and EVAL, while product performance ranges from conventional low- and medium-flux membranes to high-flux, medium cut-off and high cut-off designs. This study focuses on Blood Purification Membrane products used in hospital hemodialysis units, independent dialysis centers and home dialysis environments.
Key Findings
Synthetic membranes remain the core platform for mainstream blood purification membranes
High-flux and sharper cut-off designs are advancing product differentiation
Middle-molecule clearance and albumin retention define next-generation performance priorities
Institutional dialysis settings remain the principal downstream demand base
Material chemistry and hollow-fiber engineering shape competitive differentiation
Market Trends
The Blood Purification Membrane market is moving from basic solute-removal capability toward more precisely engineered separation performance. High-flux membranes remain an important commercial platform, while medium cut-off, sharp cut-off and other enhanced-permeability technologies are extending clearance toward larger middle molecules without proportionally increasing albumin loss. At the same time, membrane development is becoming increasingly multidimensional: manufacturers are optimizing polymer formulation, asymmetric pore architecture, fiber wall thickness, hydrophilicity, surface modification and blood compatibility rather than relying solely on nominal flux classification. Polysulfone and polyethersulfone continue to support broad product portfolios, while CTA, PMMA, PEPA and other differentiated materials maintain specific positions based on biocompatibility, adsorption characteristics or transport profiles. Product development is therefore increasingly centered on balancing clearance efficiency, selectivity, albumin retention, hemocompatibility and treatment stability, with membrane engineering becoming a major determinant of clinical positioning and product differentiation.
Market Dynamics
Drivers
Demand for Blood Purification Membrane is fundamentally supported by the recurring nature of maintenance hemodialysis and the continuous requirement for disposable dialyzers and filtration components. Beyond patient volume, the market is increasingly influenced by higher expectations for dialysis adequacy and broader toxin-removal performance. Clinical product development has moved beyond efficient removal of small solutes toward improved removal of middle and larger-middle molecules, creating demand for more precisely controlled membrane pore structures and permeability profiles. Expansion of high-flux dialysis, hemodiafiltration and other enhanced blood purification approaches also raises the technical requirements placed on membrane materials. At the manufacturing level, continuous improvements in hollow-fiber spinning, polymer blending and membrane surface engineering enable suppliers to improve performance while maintaining consistency at commercial production scale, supporting replacement and upgrading of established membrane platforms.
Restraints
Blood Purification Membrane manufacturing has relatively high technical and quality-control barriers because changes in polymer composition, spinning conditions, pore-size distribution or surface characteristics can affect clearance, albumin loss, blood compatibility and filtration stability. Manufacturers therefore need to maintain tight process control from polymer preparation and hollow-fiber spinning through module assembly and sterilization. More advanced permeability is not automatically equivalent to better overall performance, as higher transport capacity must be balanced against unwanted macromolecule loss and treatment safety. Product development also faces qualification and regulatory requirements associated with medical devices and blood-contacting materials, which can lengthen commercialization cycles. In addition, established dialysis systems and clinical operating protocols create switching costs, meaning new membrane technologies generally require both measurable performance differentiation and reliable manufacturing consistency before achieving broad adoption.
Opportunities
The principal opportunity lies in the transition from conventional flux-based differentiation toward membranes engineered around defined molecular-removal windows. Medium cut-off, sharp cut-off, super high-flux and related technologies demonstrate increasing industry attention to removal of larger middle molecules while preserving clinically important proteins. This creates opportunities for membrane suppliers capable of controlling pore distribution more precisely and integrating selective transport with improved hemocompatibility. Specialty membrane materials also retain opportunity where adsorption, biocompatibility or unique polymer structures provide functional differentiation beyond standard polysulfone platforms. Another opportunity is vertical integration: companies with internal capabilities in polymer formulation, hollow-fiber spinning, membrane modification and dialyzer assembly can shorten development cycles and more closely coordinate membrane performance with finished-device design. Chinese manufacturers with integrated membrane-spinning and assembly capabilities may benefit from continued localization of high-performance dialysis consumables.
Challenges
The major long-term challenge is converting incremental membrane improvements into clinically meaningful and commercially defensible differentiation. Blood Purification Membrane performance is determined by multiple interacting parameters, and improvements in clearance must be balanced against albumin retention, blood compatibility, mechanical stability and reproducibility. Competition is also moving toward increasingly sophisticated proprietary fiber structures and membrane formulations, raising R&D and process-development requirements. At the same time, dialysis consumables are used repeatedly and at large volume, making manufacturing yield, quality consistency and cost control important alongside clinical performance. New membrane technologies must therefore demonstrate not only differentiated separation characteristics but also scalable production, sterilization compatibility and stable performance across treatment conditions. The need to satisfy both clinical and economic requirements can slow the adoption of technologies whose performance gains are insufficiently differentiated from established high-flux products.
Industry Chain Analysis
The upstream value base of the Blood Purification Membrane industry consists primarily of medical-grade polymer resins and cellulose derivatives, membrane-forming solvents and additives, hydrophilic modifiers, potting and housing materials, together with precision hollow-fiber spinning, extrusion and inspection equipment. Polymer purity, molecular-weight distribution, formulation stability and raw-material consistency have direct influence on membrane morphology and production yield. In the midstream, value creation is concentrated in polymer formulation, spinning solution preparation, hollow-fiber extrusion, phase separation, pore-structure control, surface modification, washing, drying or wet preservation, module assembly and sterilization. These steps determine permeability, selectivity, blood compatibility and manufacturing consistency. Downstream, membranes are integrated into dialyzers and related blood purification filters and ultimately consumed through hospital dialysis units, independent dialysis centers and home dialysis channels. Compared with standardized structural components, a greater proportion of technological differentiation is concentrated in membrane formulation, fiber formation and pore-control capabilities; manufacturers that integrate membrane spinning with dialyzer assembly can more directly optimize membrane properties, housing design and overall clearance performance as a single system.
Segment Insights
By membrane material, synthetic polymer membranes constitute the main technology platform, with polysulfone and polyethersulfone supporting a broad range of commercial hemodialysis products because they can be engineered across different permeability and clearance levels. The market nevertheless remains technologically diversified: cellulose triacetate emphasizes a differentiated blood-contact material route, PMMA combines filtration with characteristic protein adsorption, and PEPA uses a polymer-alloy structure to achieve differentiated transport and endotoxin-retention characteristics. These specialty materials therefore compete less through simple material substitution and more through specific performance profiles.
By permeability and cut-off characteristics, the competitive focus is progressively shifting toward high-flux and more selectively engineered membrane structures. Low- and medium-flux products continue to address established treatment requirements, while high-flux products provide stronger small- and middle-molecule clearance. Medium cut-off, high cut-off and newer sharp cut-off designs extend the technical frontier by narrowing the balance between enhanced removal of larger molecules and retention of albumin. Sterilization method and dry-versus-wet product configuration represent additional product-engineering dimensions because they affect manufacturing processes, storage, handling and membrane conditioning. These segmentation dimensions increasingly interact rather than operate independently, making membrane design a multi-parameter optimization problem.
Downstream Market Opportunities
Hospital hemodialysis units and independent dialysis centers remain the principal downstream environments for Blood Purification Membrane consumption because recurring treatments generate continuous demand for single-use dialyzers and related filtration products. In these institutional settings, purchasing decisions increasingly balance clearance performance, treatment compatibility, operating convenience, supply reliability and overall consumable economics. Home dialysis represents a smaller but strategically relevant application direction, where standardized preparation, reliable membrane performance and user-friendly consumable design become particularly important. Across downstream settings, the opportunity is gradually shifting from supplying a generic filtration medium toward matching membrane characteristics to specific therapy objectives, including conventional hemodialysis, high-flux treatment and broader middle-molecule removal. Suppliers capable of linking membrane performance with complete dialyzer design and treatment protocols are therefore positioned to capture more value than suppliers competing primarily on basic membrane capacity.
Regional Insights
Regional development of the Blood Purification Membrane industry reflects differences in dialysis infrastructure, local manufacturing capability and membrane technology accumulation. Japan has a particularly diversified technology base across polysulfone, polyethersulfone, CTA, PMMA and PEPA membrane platforms, supported by multiple established manufacturers with proprietary membrane technologies. Europe combines large integrated dialysis-system suppliers with specialized membrane and filtration capabilities, while the North American market remains an important commercialization environment for advanced high-flux and expanded-hemodialysis technologies. China is increasingly characterized by localization of hollow-fiber membrane spinning and dialyzer assembly, with domestic suppliers developing integrated production capabilities rather than relying solely on imported membrane components. As a result, regional competition is becoming less dependent on simple production capacity and more dependent on membrane formulation, manufacturing consistency, clinical positioning and integration with local dialysis delivery systems.
Competitive Landscape Analysis
Competition in Blood Purification Membrane is technology-led and closely linked to vertical integration in the dialysis consumables industry. Fresenius Medical Care, Asahi Kasei Medical, Nikkiso, Nipro, Toray, B. Braun, Vantive and SB-KAWASUMI participate through differentiated dialyzer and membrane platforms, while MEDICA contributes specialized hollow-fiber membrane capabilities and WEGO represents an increasingly integrated Chinese supply model. The competitive basis is not limited to membrane material choice: companies differentiate through polymer formulation, proprietary hollow-fiber structures, permeability profiles, surface engineering, adsorption characteristics, albumin retention, sterilization design and integration between membrane and dialyzer architecture. Established suppliers benefit from accumulated membrane-processing expertise, validated manufacturing processes and broad dialysis-product portfolios, while newer product development is concentrating on high-flux, MCO, sharp cut-off and other advanced separation profiles. Chinese suppliers are strengthening internal membrane-spinning and assembly capabilities, increasing competition in localized supply and manufacturing integration. The market therefore exhibits a combination of established global dialysis platforms, specialized membrane technologies and emerging vertically integrated regional manufacturers rather than a single standardized technology route.
Report Scope
LP Information, Inc. (LPI) ' newest research report, the “Blood Purification Membrane Industry Forecast” looks at past sales and reviews total world Blood Purification Membrane sales in 2025, providing a comprehensive analysis by region and market sector of projected Blood Purification Membrane sales for 2026 through 2032. With Blood Purification Membrane sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Blood Purification Membrane industry.
This Insight Report provides a comprehensive analysis of the global Blood Purification Membrane landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Blood Purification Membrane portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Blood Purification Membrane market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Blood Purification Membrane and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Blood Purification Membrane.
This report presents a comprehensive overview, market shares, and growth opportunities of Blood Purification Membrane market by product type, application, key manufacturers and key regions and countries.
Market Segmentation
Segmentation by Type:
- Polysulfone (PSf) Membrane
- Polyethersulfone (PES) Membrane
- Other
Segmentation by Membrane Permeability:
- Low-Flux Membrane
- Medium-Flux Membrane
- High-Flux Membrane
Segmentation by Membrane Storage Condition:
- Dry-Type Membrane
- Wet-Type Membrane
Segmentation by Application:
- Hemodialyzer
- Hemofilter
- Hemoperfusion Cartridge
- Other
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Fresenius
- Vantive Health
- Nipro
- Asahi Kasei
- B. Braun
- Wego
- Toray
- Toyobo
- 3M
- Kaneka Corporation
- Kuraray
- Mitsubishi Chemical
- Evonik Industries
- Sartorius
Key Questions Addressed in this Report
- What is the 10-year outlook for the global Blood Purification Membrane market?
- What factors are driving Blood Purification Membrane market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Blood Purification Membrane market opportunities vary by end market size?
- How does Blood Purification Membrane break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Blood Purification Membrane Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Blood Purification Membrane by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Blood Purification Membrane by Country/Region, 2021, 2025 & 2032
2.2 Blood Purification Membrane Segment by Type
2.2.1 Polysulfone (PSf) Membrane
2.2.2 Polyethersulfone (PES) Membrane
2.2.3 Other
2.2.4 Blood Purification Membrane Sales by Type
2.2.4.1 Global Blood Purification Membrane Sales Market Share by Type (2021-2026)
2.2.4.2 Global Blood Purification Membrane Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Blood Purification Membrane Sale Price by Type (2021-2026)
2.3 Blood Purification Membrane Segment by Membrane Permeability
2.3.1 Low-Flux Membrane
2.3.2 Medium-Flux Membrane
2.3.3 High-Flux Membrane
2.3.4 Blood Purification Membrane Sales by Membrane Permeability
2.3.4.1 Global Blood Purification Membrane Sales Market Share by Membrane Permeability (2021-2026)
2.3.4.2 Global Blood Purification Membrane Revenue and Market Share by Membrane Permeability (2021-2026)
2.3.4.3 Global Blood Purification Membrane Sale Price by Membrane Permeability (2021-2026)
2.4 Blood Purification Membrane Segment by Membrane Storage Condition
2.4.1 Dry-Type Membrane
2.4.2 Wet-Type Membrane
2.4.3 Blood Purification Membrane Sales by Membrane Storage Condition
2.4.3.1 Global Blood Purification Membrane Sales Market Share by Membrane Storage Condition (2021-2026)
2.4.3.2 Global Blood Purification Membrane Revenue and Market Share by Membrane Storage Condition (2021-2026)
2.4.3.3 Global Blood Purification Membrane Sale Price by Membrane Storage Condition (2021-2026)
2.5 Blood Purification Membrane Segment by Application
2.5.1 Hemodialyzer
2.5.2 Hemofilter
2.5.3 Hemoperfusion Cartridge
2.5.4 Other
2.5.5 Blood Purification Membrane Sales by Application
2.5.5.1 Global Blood Purification Membrane Sale Market Share by Application (2021-2026)
2.5.5.2 Global Blood Purification Membrane Revenue and Market Share by Application (2021-2026)
2.5.5.3 Global Blood Purification Membrane Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Blood Purification Membrane Breakdown Data by Company
3.1.1 Global Blood Purification Membrane Annual Sales by Company (2021-2026)
3.1.2 Global Blood Purification Membrane Sales Market Share by Company (2021-2026)
3.2 Global Blood Purification Membrane Annual Revenue by Company (2021-2026)
3.2.1 Global Blood Purification Membrane Revenue by Company (2021-2026)
3.2.2 Global Blood Purification Membrane Revenue Market Share by Company (2021-2026)
3.3 Global Blood Purification Membrane Sale Price by Company
3.4 Key Manufacturers Blood Purification Membrane Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Blood Purification Membrane Product Location Distribution
3.4.2 Players Blood Purification Membrane Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR BLOOD PURIFICATION MEMBRANE BY GEOGRAPHIC REGION
4.1 World Historic Blood Purification Membrane Market Size by Geographic Region (2021-2026)
4.1.1 Global Blood Purification Membrane Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Blood Purification Membrane Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Blood Purification Membrane Market Size by Country/Region (2021-2026)
4.2.1 Global Blood Purification Membrane Annual Sales by Country/Region (2021-2026)
4.2.2 Global Blood Purification Membrane Annual Revenue by Country/Region (2021-2026)
4.3 Americas Blood Purification Membrane Sales Growth
4.4 APAC Blood Purification Membrane Sales Growth
4.5 Europe Blood Purification Membrane Sales Growth
4.6 Middle East & Africa Blood Purification Membrane Sales Growth
5 AMERICAS
5.1 Americas Blood Purification Membrane Sales by Country
5.1.1 Americas Blood Purification Membrane Sales by Country (2021-2026)
5.1.2 Americas Blood Purification Membrane Revenue by Country (2021-2026)
5.2 Americas Blood Purification Membrane Sales by Type (2021-2026)
5.3 Americas Blood Purification Membrane Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Blood Purification Membrane Sales by Region
6.1.1 APAC Blood Purification Membrane Sales by Region (2021-2026)
6.1.2 APAC Blood Purification Membrane Revenue by Region (2021-2026)
6.2 APAC Blood Purification Membrane Sales by Type (2021-2026)
6.3 APAC Blood Purification Membrane Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Blood Purification Membrane by Country
7.1.1 Europe Blood Purification Membrane Sales by Country (2021-2026)
7.1.2 Europe Blood Purification Membrane Revenue by Country (2021-2026)
7.2 Europe Blood Purification Membrane Sales by Type (2021-2026)
7.3 Europe Blood Purification Membrane Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Blood Purification Membrane by Country
8.1.1 Middle East & Africa Blood Purification Membrane Sales by Country (2021-2026)
8.1.2 Middle East & Africa Blood Purification Membrane Revenue by Country (2021-2026)
8.2 Middle East & Africa Blood Purification Membrane Sales by Type (2021-2026)
8.3 Middle East & Africa Blood Purification Membrane Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Blood Purification Membrane
10.3 Manufacturing Process Analysis of Blood Purification Membrane
10.4 Industry Chain Structure of Blood Purification Membrane
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Blood Purification Membrane Distributors
11.3 Blood Purification Membrane Customer
12 WORLD FORECAST REVIEW FOR BLOOD PURIFICATION MEMBRANE BY GEOGRAPHIC REGION
12.1 Global Blood Purification Membrane Market Size Forecast by Region
12.1.1 Global Blood Purification Membrane Forecast by Region (2027-2032)
12.1.2 Global Blood Purification Membrane Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Blood Purification Membrane Forecast by Type (2027-2032)
12.7 Global Blood Purification Membrane Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Fresenius
13.1.1 Fresenius Company Information
13.1.2 Fresenius Blood Purification Membrane Product Portfolios and Specifications
13.1.3 Fresenius Blood Purification Membrane Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Fresenius Main Business Overview
13.1.5 Fresenius Latest Developments
13.2 Vantive Health
13.2.1 Vantive Health Company Information
13.2.2 Vantive Health Blood Purification Membrane Product Portfolios and Specifications
13.2.3 Vantive Health Blood Purification Membrane Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Vantive Health Main Business Overview
13.2.5 Vantive Health Latest Developments
13.3 Nipro
13.3.1 Nipro Company Information
13.3.2 Nipro Blood Purification Membrane Product Portfolios and Specifications
13.3.3 Nipro Blood Purification Membrane Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Nipro Main Business Overview
13.3.5 Nipro Latest Developments
13.4 Asahi Kasei
13.4.1 Asahi Kasei Company Information
13.4.2 Asahi Kasei Blood Purification Membrane Product Portfolios and Specifications
13.4.3 Asahi Kasei Blood Purification Membrane Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Asahi Kasei Main Business Overview
13.4.5 Asahi Kasei Latest Developments
13.5 B. Braun
13.5.1 B. Braun Company Information
13.5.2 B. Braun Blood Purification Membrane Product Portfolios and Specifications
13.5.3 B. Braun Blood Purification Membrane Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 B. Braun Main Business Overview
13.5.5 B. Braun Latest Developments
13.6 Wego
13.6.1 Wego Company Information
13.6.2 Wego Blood Purification Membrane Product Portfolios and Specifications
13.6.3 Wego Blood Purification Membrane Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Wego Main Business Overview
13.6.5 Wego Latest Developments
13.7 Toray
13.7.1 Toray Company Information
13.7.2 Toray Blood Purification Membrane Product Portfolios and Specifications
13.7.3 Toray Blood Purification Membrane Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Toray Main Business Overview
13.7.5 Toray Latest Developments
13.8 Toyobo
13.8.1 Toyobo Company Information
13.8.2 Toyobo Blood Purification Membrane Product Portfolios and Specifications
13.8.3 Toyobo Blood Purification Membrane Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Toyobo Main Business Overview
13.8.5 Toyobo Latest Developments
13.9 3M
13.9.1 3M Company Information
13.9.2 3M Blood Purification Membrane Product Portfolios and Specifications
13.9.3 3M Blood Purification Membrane Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 3M Main Business Overview
13.9.5 3M Latest Developments
13.10 Kaneka Corporation
13.10.1 Kaneka Corporation Company Information
13.10.2 Kaneka Corporation Blood Purification Membrane Product Portfolios and Specifications
13.10.3 Kaneka Corporation Blood Purification Membrane Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Kaneka Corporation Main Business Overview
13.10.5 Kaneka Corporation Latest Developments
13.11 Kuraray
13.11.1 Kuraray Company Information
13.11.2 Kuraray Blood Purification Membrane Product Portfolios and Specifications
13.11.3 Kuraray Blood Purification Membrane Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Kuraray Main Business Overview
13.11.5 Kuraray Latest Developments
13.12 Mitsubishi Chemical
13.12.1 Mitsubishi Chemical Company Information
13.12.2 Mitsubishi Chemical Blood Purification Membrane Product Portfolios and Specifications
13.12.3 Mitsubishi Chemical Blood Purification Membrane Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Mitsubishi Chemical Main Business Overview
13.12.5 Mitsubishi Chemical Latest Developments
13.13 Evonik Industries
13.13.1 Evonik Industries Company Information
13.13.2 Evonik Industries Blood Purification Membrane Product Portfolios and Specifications
13.13.3 Evonik Industries Blood Purification Membrane Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Evonik Industries Main Business Overview
13.13.5 Evonik Industries Latest Developments
13.14 Sartorius
13.14.1 Sartorius Company Information
13.14.2 Sartorius Blood Purification Membrane Product Portfolios and Specifications
13.14.3 Sartorius Blood Purification Membrane Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Sartorius Main Business Overview
13.14.5 Sartorius Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Blood Purification Membrane Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Blood Purification Membrane by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Blood Purification Membrane by Country/Region, 2021, 2025 & 2032
2.2 Blood Purification Membrane Segment by Type
2.2.1 Polysulfone (PSf) Membrane
2.2.2 Polyethersulfone (PES) Membrane
2.2.3 Other
2.2.4 Blood Purification Membrane Sales by Type
2.2.4.1 Global Blood Purification Membrane Sales Market Share by Type (2021-2026)
2.2.4.2 Global Blood Purification Membrane Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Blood Purification Membrane Sale Price by Type (2021-2026)
2.3 Blood Purification Membrane Segment by Membrane Permeability
2.3.1 Low-Flux Membrane
2.3.2 Medium-Flux Membrane
2.3.3 High-Flux Membrane
2.3.4 Blood Purification Membrane Sales by Membrane Permeability
2.3.4.1 Global Blood Purification Membrane Sales Market Share by Membrane Permeability (2021-2026)
2.3.4.2 Global Blood Purification Membrane Revenue and Market Share by Membrane Permeability (2021-2026)
2.3.4.3 Global Blood Purification Membrane Sale Price by Membrane Permeability (2021-2026)
2.4 Blood Purification Membrane Segment by Membrane Storage Condition
2.4.1 Dry-Type Membrane
2.4.2 Wet-Type Membrane
2.4.3 Blood Purification Membrane Sales by Membrane Storage Condition
2.4.3.1 Global Blood Purification Membrane Sales Market Share by Membrane Storage Condition (2021-2026)
2.4.3.2 Global Blood Purification Membrane Revenue and Market Share by Membrane Storage Condition (2021-2026)
2.4.3.3 Global Blood Purification Membrane Sale Price by Membrane Storage Condition (2021-2026)
2.5 Blood Purification Membrane Segment by Application
2.5.1 Hemodialyzer
2.5.2 Hemofilter
2.5.3 Hemoperfusion Cartridge
2.5.4 Other
2.5.5 Blood Purification Membrane Sales by Application
2.5.5.1 Global Blood Purification Membrane Sale Market Share by Application (2021-2026)
2.5.5.2 Global Blood Purification Membrane Revenue and Market Share by Application (2021-2026)
2.5.5.3 Global Blood Purification Membrane Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Blood Purification Membrane Breakdown Data by Company
3.1.1 Global Blood Purification Membrane Annual Sales by Company (2021-2026)
3.1.2 Global Blood Purification Membrane Sales Market Share by Company (2021-2026)
3.2 Global Blood Purification Membrane Annual Revenue by Company (2021-2026)
3.2.1 Global Blood Purification Membrane Revenue by Company (2021-2026)
3.2.2 Global Blood Purification Membrane Revenue Market Share by Company (2021-2026)
3.3 Global Blood Purification Membrane Sale Price by Company
3.4 Key Manufacturers Blood Purification Membrane Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Blood Purification Membrane Product Location Distribution
3.4.2 Players Blood Purification Membrane Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR BLOOD PURIFICATION MEMBRANE BY GEOGRAPHIC REGION
4.1 World Historic Blood Purification Membrane Market Size by Geographic Region (2021-2026)
4.1.1 Global Blood Purification Membrane Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Blood Purification Membrane Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Blood Purification Membrane Market Size by Country/Region (2021-2026)
4.2.1 Global Blood Purification Membrane Annual Sales by Country/Region (2021-2026)
4.2.2 Global Blood Purification Membrane Annual Revenue by Country/Region (2021-2026)
4.3 Americas Blood Purification Membrane Sales Growth
4.4 APAC Blood Purification Membrane Sales Growth
4.5 Europe Blood Purification Membrane Sales Growth
4.6 Middle East & Africa Blood Purification Membrane Sales Growth
5 AMERICAS
5.1 Americas Blood Purification Membrane Sales by Country
5.1.1 Americas Blood Purification Membrane Sales by Country (2021-2026)
5.1.2 Americas Blood Purification Membrane Revenue by Country (2021-2026)
5.2 Americas Blood Purification Membrane Sales by Type (2021-2026)
5.3 Americas Blood Purification Membrane Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Blood Purification Membrane Sales by Region
6.1.1 APAC Blood Purification Membrane Sales by Region (2021-2026)
6.1.2 APAC Blood Purification Membrane Revenue by Region (2021-2026)
6.2 APAC Blood Purification Membrane Sales by Type (2021-2026)
6.3 APAC Blood Purification Membrane Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Blood Purification Membrane by Country
7.1.1 Europe Blood Purification Membrane Sales by Country (2021-2026)
7.1.2 Europe Blood Purification Membrane Revenue by Country (2021-2026)
7.2 Europe Blood Purification Membrane Sales by Type (2021-2026)
7.3 Europe Blood Purification Membrane Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Blood Purification Membrane by Country
8.1.1 Middle East & Africa Blood Purification Membrane Sales by Country (2021-2026)
8.1.2 Middle East & Africa Blood Purification Membrane Revenue by Country (2021-2026)
8.2 Middle East & Africa Blood Purification Membrane Sales by Type (2021-2026)
8.3 Middle East & Africa Blood Purification Membrane Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Blood Purification Membrane
10.3 Manufacturing Process Analysis of Blood Purification Membrane
10.4 Industry Chain Structure of Blood Purification Membrane
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Blood Purification Membrane Distributors
11.3 Blood Purification Membrane Customer
12 WORLD FORECAST REVIEW FOR BLOOD PURIFICATION MEMBRANE BY GEOGRAPHIC REGION
12.1 Global Blood Purification Membrane Market Size Forecast by Region
12.1.1 Global Blood Purification Membrane Forecast by Region (2027-2032)
12.1.2 Global Blood Purification Membrane Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Blood Purification Membrane Forecast by Type (2027-2032)
12.7 Global Blood Purification Membrane Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Fresenius
13.1.1 Fresenius Company Information
13.1.2 Fresenius Blood Purification Membrane Product Portfolios and Specifications
13.1.3 Fresenius Blood Purification Membrane Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Fresenius Main Business Overview
13.1.5 Fresenius Latest Developments
13.2 Vantive Health
13.2.1 Vantive Health Company Information
13.2.2 Vantive Health Blood Purification Membrane Product Portfolios and Specifications
13.2.3 Vantive Health Blood Purification Membrane Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Vantive Health Main Business Overview
13.2.5 Vantive Health Latest Developments
13.3 Nipro
13.3.1 Nipro Company Information
13.3.2 Nipro Blood Purification Membrane Product Portfolios and Specifications
13.3.3 Nipro Blood Purification Membrane Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Nipro Main Business Overview
13.3.5 Nipro Latest Developments
13.4 Asahi Kasei
13.4.1 Asahi Kasei Company Information
13.4.2 Asahi Kasei Blood Purification Membrane Product Portfolios and Specifications
13.4.3 Asahi Kasei Blood Purification Membrane Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Asahi Kasei Main Business Overview
13.4.5 Asahi Kasei Latest Developments
13.5 B. Braun
13.5.1 B. Braun Company Information
13.5.2 B. Braun Blood Purification Membrane Product Portfolios and Specifications
13.5.3 B. Braun Blood Purification Membrane Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 B. Braun Main Business Overview
13.5.5 B. Braun Latest Developments
13.6 Wego
13.6.1 Wego Company Information
13.6.2 Wego Blood Purification Membrane Product Portfolios and Specifications
13.6.3 Wego Blood Purification Membrane Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Wego Main Business Overview
13.6.5 Wego Latest Developments
13.7 Toray
13.7.1 Toray Company Information
13.7.2 Toray Blood Purification Membrane Product Portfolios and Specifications
13.7.3 Toray Blood Purification Membrane Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Toray Main Business Overview
13.7.5 Toray Latest Developments
13.8 Toyobo
13.8.1 Toyobo Company Information
13.8.2 Toyobo Blood Purification Membrane Product Portfolios and Specifications
13.8.3 Toyobo Blood Purification Membrane Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Toyobo Main Business Overview
13.8.5 Toyobo Latest Developments
13.9 3M
13.9.1 3M Company Information
13.9.2 3M Blood Purification Membrane Product Portfolios and Specifications
13.9.3 3M Blood Purification Membrane Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 3M Main Business Overview
13.9.5 3M Latest Developments
13.10 Kaneka Corporation
13.10.1 Kaneka Corporation Company Information
13.10.2 Kaneka Corporation Blood Purification Membrane Product Portfolios and Specifications
13.10.3 Kaneka Corporation Blood Purification Membrane Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Kaneka Corporation Main Business Overview
13.10.5 Kaneka Corporation Latest Developments
13.11 Kuraray
13.11.1 Kuraray Company Information
13.11.2 Kuraray Blood Purification Membrane Product Portfolios and Specifications
13.11.3 Kuraray Blood Purification Membrane Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Kuraray Main Business Overview
13.11.5 Kuraray Latest Developments
13.12 Mitsubishi Chemical
13.12.1 Mitsubishi Chemical Company Information
13.12.2 Mitsubishi Chemical Blood Purification Membrane Product Portfolios and Specifications
13.12.3 Mitsubishi Chemical Blood Purification Membrane Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Mitsubishi Chemical Main Business Overview
13.12.5 Mitsubishi Chemical Latest Developments
13.13 Evonik Industries
13.13.1 Evonik Industries Company Information
13.13.2 Evonik Industries Blood Purification Membrane Product Portfolios and Specifications
13.13.3 Evonik Industries Blood Purification Membrane Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Evonik Industries Main Business Overview
13.13.5 Evonik Industries Latest Developments
13.14 Sartorius
13.14.1 Sartorius Company Information
13.14.2 Sartorius Blood Purification Membrane Product Portfolios and Specifications
13.14.3 Sartorius Blood Purification Membrane Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Sartorius Main Business Overview
13.14.5 Sartorius Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Blood Purification Membrane Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Blood Purification Membrane Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Polysulfone (PSf) Membrane
Table 4. Major Players of Polyethersulfone (PES) Membrane
Table 5. Major Players of Other
Table 6. Global Blood Purification Membrane Sales by Type (2021-2026) & (K Sqm)
Table 7. Global Blood Purification Membrane Sales Market Share by Type (2021-2026)
Table 8. Global Blood Purification Membrane Revenue by Type (2021-2026) & ($ million)
Table 9. Global Blood Purification Membrane Revenue Market Share by Type (2021-2026)
Table 10. Global Blood Purification Membrane Sale Price by Type (2021-2026) & (US$/Sq m)
Table 11. Major Players of Low-Flux Membrane
Table 12. Major Players of Medium-Flux Membrane
Table 13. Major Players of High-Flux Membrane
Table 14. Global Blood Purification Membrane Sales by Membrane Permeability (2021-2026) & (K Sqm)
Table 15. Global Blood Purification Membrane Sales Market Share by Membrane Permeability (2021-2026)
Table 16. Global Blood Purification Membrane Revenue by Membrane Permeability (2021-2026) & ($ million)
Table 17. Global Blood Purification Membrane Revenue Market Share by Membrane Permeability (2021-2026)
Table 18. Global Blood Purification Membrane Sale Price by Membrane Permeability (2021-2026) & (US$/Sq m)
Table 19. Major Players of Dry-Type Membrane
Table 20. Major Players of Wet-Type Membrane
Table 21. Global Blood Purification Membrane Sales by Membrane Storage Condition (2021-2026) & (K Sqm)
Table 22. Global Blood Purification Membrane Sales Market Share by Membrane Storage Condition (2021-2026)
Table 23. Global Blood Purification Membrane Revenue by Membrane Storage Condition (2021-2026) & ($ million)
Table 24. Global Blood Purification Membrane Revenue Market Share by Membrane Storage Condition (2021-2026)
Table 25. Global Blood Purification Membrane Sale Price by Membrane Storage Condition (2021-2026) & (US$/Sq m)
Table 26. Global Blood Purification Membrane Sale by Application (2021-2026) & (K Sqm)
Table 27. Global Blood Purification Membrane Sale Market Share by Application (2021-2026)
Table 28. Global Blood Purification Membrane Revenue by Application (2021-2026) & ($ million)
Table 29. Global Blood Purification Membrane Revenue Market Share by Application (2021-2026)
Table 30. Global Blood Purification Membrane Sale Price by Application (2021-2026) & (US$/Sq m)
Table 31. Global Blood Purification Membrane Sales by Company (2021-2026) & (K Sqm)
Table 32. Global Blood Purification Membrane Sales Market Share by Company (2021-2026)
Table 33. Global Blood Purification Membrane Revenue by Company (2021-2026) & ($ millions)
Table 34. Global Blood Purification Membrane Revenue Market Share by Company (2021-2026)
Table 35. Global Blood Purification Membrane Sale Price by Company (2021-2026) & (US$/Sq m)
Table 36. Key Manufacturers Blood Purification Membrane Producing Area Distribution and Sales Area
Table 37. Players Blood Purification Membrane Products Offered
Table 38. Blood Purification Membrane Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 39. New Products and Potential Entrants
Table 40. Market M&A Activity & Strategy
Table 41. Global Blood Purification Membrane Sales by Geographic Region (2021-2026) & (K Sqm)
Table 42. Global Blood Purification Membrane Sales Market Share Geographic Region (2021-2026)
Table 43. Global Blood Purification Membrane Revenue by Geographic Region (2021-2026) & ($ millions)
Table 44. Global Blood Purification Membrane Revenue Market Share by Geographic Region (2021-2026)
Table 45. Global Blood Purification Membrane Sales by Country/Region (2021-2026) & (K Sqm)
Table 46. Global Blood Purification Membrane Sales Market Share by Country/Region (2021-2026)
Table 47. Global Blood Purification Membrane Revenue by Country/Region (2021-2026) & ($ millions)
Table 48. Global Blood Purification Membrane Revenue Market Share by Country/Region (2021-2026)
Table 49. Americas Blood Purification Membrane Sales by Country (2021-2026) & (K Sqm)
Table 50. Americas Blood Purification Membrane Sales Market Share by Country (2021-2026)
Table 51. Americas Blood Purification Membrane Revenue by Country (2021-2026) & ($ millions)
Table 52. Americas Blood Purification Membrane Sales by Type (2021-2026) & (K Sqm)
Table 53. Americas Blood Purification Membrane Sales by Application (2021-2026) & (K Sqm)
Table 54. APAC Blood Purification Membrane Sales by Region (2021-2026) & (K Sqm)
Table 55. APAC Blood Purification Membrane Sales Market Share by Region (2021-2026)
Table 56. APAC Blood Purification Membrane Revenue by Region (2021-2026) & ($ millions)
Table 57. APAC Blood Purification Membrane Sales by Type (2021-2026) & (K Sqm)
Table 58. APAC Blood Purification Membrane Sales by Application (2021-2026) & (K Sqm)
Table 59. Europe Blood Purification Membrane Sales by Country (2021-2026) & (K Sqm)
Table 60. Europe Blood Purification Membrane Revenue by Country (2021-2026) & ($ millions)
Table 61. Europe Blood Purification Membrane Sales by Type (2021-2026) & (K Sqm)
Table 62. Europe Blood Purification Membrane Sales by Application (2021-2026) & (K Sqm)
Table 63. Middle East & Africa Blood Purification Membrane Sales by Country (2021-2026) & (K Sqm)
Table 64. Middle East & Africa Blood Purification Membrane Revenue Market Share by Country (2021-2026)
Table 65. Middle East & Africa Blood Purification Membrane Sales by Type (2021-2026) & (K Sqm)
Table 66. Middle East & Africa Blood Purification Membrane Sales by Application (2021-2026) & (K Sqm)
Table 67. Key Market Drivers & Growth Opportunities of Blood Purification Membrane
Table 68. Key Market Challenges & Risks of Blood Purification Membrane
Table 69. Key Industry Trends of Blood Purification Membrane
Table 70. Blood Purification Membrane Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Blood Purification Membrane Distributors List
Table 73. Blood Purification Membrane Customer List
Table 74. Global Blood Purification Membrane Sales Forecast by Region (2027-2032) & (K Sqm)
Table 75. Global Blood Purification Membrane Revenue Forecast by Region (2027-2032) & ($ millions)
Table 76. Americas Blood Purification Membrane Sales Forecast by Country (2027-2032) & (K Sqm)
Table 77. Americas Blood Purification Membrane Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 78. APAC Blood Purification Membrane Sales Forecast by Region (2027-2032) & (K Sqm)
Table 79. APAC Blood Purification Membrane Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 80. Europe Blood Purification Membrane Sales Forecast by Country (2027-2032) & (K Sqm)
Table 81. Europe Blood Purification Membrane Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. Middle East & Africa Blood Purification Membrane Sales Forecast by Country (2027-2032) & (K Sqm)
Table 83. Middle East & Africa Blood Purification Membrane Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. Global Blood Purification Membrane Sales Forecast by Type (2027-2032) & (K Sqm)
Table 85. Global Blood Purification Membrane Revenue Forecast by Type (2027-2032) & ($ millions)
Table 86. Global Blood Purification Membrane Sales Forecast by Application (2027-2032) & (K Sqm)
Table 87. Global Blood Purification Membrane Revenue Forecast by Application (2027-2032) & ($ millions)
Table 88. Fresenius Basic Information, Blood Purification Membrane Manufacturing Base, Sales Area and Its Competitors
Table 89. Fresenius Blood Purification Membrane Product Portfolios and Specifications
Table 90. Fresenius Blood Purification Membrane Sales (K Sqm), Revenue ($ Million), Price (US$/Sq m) and Gross Margin (2021-2026)
Table 91. Fresenius Main Business
Table 92. Fresenius Latest Developments
Table 93. Vantive Health Basic Information, Blood Purification Membrane Manufacturing Base, Sales Area and Its Competitors
Table 94. Vantive Health Blood Purification Membrane Product Portfolios and Specifications
Table 95. Vantive Health Blood Purification Membrane Sales (K Sqm), Revenue ($ Million), Price (US$/Sq m) and Gross Margin (2021-2026)
Table 96. Vantive Health Main Business
Table 97. Vantive Health Latest Developments
Table 98. Nipro Basic Information, Blood Purification Membrane Manufacturing Base, Sales Area and Its Competitors
Table 99. Nipro Blood Purification Membrane Product Portfolios and Specifications
Table 100. Nipro Blood Purification Membrane Sales (K Sqm), Revenue ($ Million), Price (US$/Sq m) and Gross Margin (2021-2026)
Table 101. Nipro Main Business
Table 102. Nipro Latest Developments
Table 103. Asahi Kasei Basic Information, Blood Purification Membrane Manufacturing Base, Sales Area and Its Competitors
Table 104. Asahi Kasei Blood Purification Membrane Product Portfolios and Specifications
Table 105. Asahi Kasei Blood Purification Membrane Sales (K Sqm), Revenue ($ Million), Price (US$/Sq m) and Gross Margin (2021-2026)
Table 106. Asahi Kasei Main Business
Table 107. Asahi Kasei Latest Developments
Table 108. B. Braun Basic Information, Blood Purification Membrane Manufacturing Base, Sales Area and Its Competitors
Table 109. B. Braun Blood Purification Membrane Product Portfolios and Specifications
Table 110. B. Braun Blood Purification Membrane Sales (K Sqm), Revenue ($ Million), Price (US$/Sq m) and Gross Margin (2021-2026)
Table 111. B. Braun Main Business
Table 112. B. Braun Latest Developments
Table 113. Wego Basic Information, Blood Purification Membrane Manufacturing Base, Sales Area and Its Competitors
Table 114. Wego Blood Purification Membrane Product Portfolios and Specifications
Table 115. Wego Blood Purification Membrane Sales (K Sqm), Revenue ($ Million), Price (US$/Sq m) and Gross Margin (2021-2026)
Table 116. Wego Main Business
Table 117. Wego Latest Developments
Table 118. Toray Basic Information, Blood Purification Membrane Manufacturing Base, Sales Area and Its Competitors
Table 119. Toray Blood Purification Membrane Product Portfolios and Specifications
Table 120. Toray Blood Purification Membrane Sales (K Sqm), Revenue ($ Million), Price (US$/Sq m) and Gross Margin (2021-2026)
Table 121. Toray Main Business
Table 122. Toray Latest Developments
Table 123. Toyobo Basic Information, Blood Purification Membrane Manufacturing Base, Sales Area and Its Competitors
Table 124. Toyobo Blood Purification Membrane Product Portfolios and Specifications
Table 125. Toyobo Blood Purification Membrane Sales (K Sqm), Revenue ($ Million), Price (US$/Sq m) and Gross Margin (2021-2026)
Table 126. Toyobo Main Business
Table 127. Toyobo Latest Developments
Table 128. 3M Basic Information, Blood Purification Membrane Manufacturing Base, Sales Area and Its Competitors
Table 129. 3M Blood Purification Membrane Product Portfolios and Specifications
Table 130. 3M Blood Purification Membrane Sales (K Sqm), Revenue ($ Million), Price (US$/Sq m) and Gross Margin (2021-2026)
Table 131. 3M Main Business
Table 132. 3M Latest Developments
Table 133. Kaneka Corporation Basic Information, Blood Purification Membrane Manufacturing Base, Sales Area and Its Competitors
Table 134. Kaneka Corporation Blood Purification Membrane Product Portfolios and Specifications
Table 135. Kaneka Corporation Blood Purification Membrane Sales (K Sqm), Revenue ($ Million), Price (US$/Sq m) and Gross Margin (2021-2026)
Table 136. Kaneka Corporation Main Business
Table 137. Kaneka Corporation Latest Developments
Table 138. Kuraray Basic Information, Blood Purification Membrane Manufacturing Base, Sales Area and Its Competitors
Table 139. Kuraray Blood Purification Membrane Product Portfolios and Specifications
Table 140. Kuraray Blood Purification Membrane Sales (K Sqm), Revenue ($ Million), Price (US$/Sq m) and Gross Margin (2021-2026)
Table 141. Kuraray Main Business
Table 142. Kuraray Latest Developments
Table 143. Mitsubishi Chemical Basic Information, Blood Purification Membrane Manufacturing Base, Sales Area and Its Competitors
Table 144. Mitsubishi Chemical Blood Purification Membrane Product Portfolios and Specifications
Table 145. Mitsubishi Chemical Blood Purification Membrane Sales (K Sqm), Revenue ($ Million), Price (US$/Sq m) and Gross Margin (2021-2026)
Table 146. Mitsubishi Chemical Main Business
Table 147. Mitsubishi Chemical Latest Developments
Table 148. Evonik Industries Basic Information, Blood Purification Membrane Manufacturing Base, Sales Area and Its Competitors
Table 149. Evonik Industries Blood Purification Membrane Product Portfolios and Specifications
Table 150. Evonik Industries Blood Purification Membrane Sales (K Sqm), Revenue ($ Million), Price (US$/Sq m) and Gross Margin (2021-2026)
Table 151. Evonik Industries Main Business
Table 152. Evonik Industries Latest Developments
Table 153. Sartorius Basic Information, Blood Purification Membrane Manufacturing Base, Sales Area and Its Competitors
Table 154. Sartorius Blood Purification Membrane Product Portfolios and Specifications
Table 155. Sartorius Blood Purification Membrane Sales (K Sqm), Revenue ($ Million), Price (US$/Sq m) and Gross Margin (2021-2026)
Table 156. Sartorius Main Business
Table 157. Sartorius Latest Developments
Table 1. Blood Purification Membrane Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Blood Purification Membrane Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Polysulfone (PSf) Membrane
Table 4. Major Players of Polyethersulfone (PES) Membrane
Table 5. Major Players of Other
Table 6. Global Blood Purification Membrane Sales by Type (2021-2026) & (K Sqm)
Table 7. Global Blood Purification Membrane Sales Market Share by Type (2021-2026)
Table 8. Global Blood Purification Membrane Revenue by Type (2021-2026) & ($ million)
Table 9. Global Blood Purification Membrane Revenue Market Share by Type (2021-2026)
Table 10. Global Blood Purification Membrane Sale Price by Type (2021-2026) & (US$/Sq m)
Table 11. Major Players of Low-Flux Membrane
Table 12. Major Players of Medium-Flux Membrane
Table 13. Major Players of High-Flux Membrane
Table 14. Global Blood Purification Membrane Sales by Membrane Permeability (2021-2026) & (K Sqm)
Table 15. Global Blood Purification Membrane Sales Market Share by Membrane Permeability (2021-2026)
Table 16. Global Blood Purification Membrane Revenue by Membrane Permeability (2021-2026) & ($ million)
Table 17. Global Blood Purification Membrane Revenue Market Share by Membrane Permeability (2021-2026)
Table 18. Global Blood Purification Membrane Sale Price by Membrane Permeability (2021-2026) & (US$/Sq m)
Table 19. Major Players of Dry-Type Membrane
Table 20. Major Players of Wet-Type Membrane
Table 21. Global Blood Purification Membrane Sales by Membrane Storage Condition (2021-2026) & (K Sqm)
Table 22. Global Blood Purification Membrane Sales Market Share by Membrane Storage Condition (2021-2026)
Table 23. Global Blood Purification Membrane Revenue by Membrane Storage Condition (2021-2026) & ($ million)
Table 24. Global Blood Purification Membrane Revenue Market Share by Membrane Storage Condition (2021-2026)
Table 25. Global Blood Purification Membrane Sale Price by Membrane Storage Condition (2021-2026) & (US$/Sq m)
Table 26. Global Blood Purification Membrane Sale by Application (2021-2026) & (K Sqm)
Table 27. Global Blood Purification Membrane Sale Market Share by Application (2021-2026)
Table 28. Global Blood Purification Membrane Revenue by Application (2021-2026) & ($ million)
Table 29. Global Blood Purification Membrane Revenue Market Share by Application (2021-2026)
Table 30. Global Blood Purification Membrane Sale Price by Application (2021-2026) & (US$/Sq m)
Table 31. Global Blood Purification Membrane Sales by Company (2021-2026) & (K Sqm)
Table 32. Global Blood Purification Membrane Sales Market Share by Company (2021-2026)
Table 33. Global Blood Purification Membrane Revenue by Company (2021-2026) & ($ millions)
Table 34. Global Blood Purification Membrane Revenue Market Share by Company (2021-2026)
Table 35. Global Blood Purification Membrane Sale Price by Company (2021-2026) & (US$/Sq m)
Table 36. Key Manufacturers Blood Purification Membrane Producing Area Distribution and Sales Area
Table 37. Players Blood Purification Membrane Products Offered
Table 38. Blood Purification Membrane Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 39. New Products and Potential Entrants
Table 40. Market M&A Activity & Strategy
Table 41. Global Blood Purification Membrane Sales by Geographic Region (2021-2026) & (K Sqm)
Table 42. Global Blood Purification Membrane Sales Market Share Geographic Region (2021-2026)
Table 43. Global Blood Purification Membrane Revenue by Geographic Region (2021-2026) & ($ millions)
Table 44. Global Blood Purification Membrane Revenue Market Share by Geographic Region (2021-2026)
Table 45. Global Blood Purification Membrane Sales by Country/Region (2021-2026) & (K Sqm)
Table 46. Global Blood Purification Membrane Sales Market Share by Country/Region (2021-2026)
Table 47. Global Blood Purification Membrane Revenue by Country/Region (2021-2026) & ($ millions)
Table 48. Global Blood Purification Membrane Revenue Market Share by Country/Region (2021-2026)
Table 49. Americas Blood Purification Membrane Sales by Country (2021-2026) & (K Sqm)
Table 50. Americas Blood Purification Membrane Sales Market Share by Country (2021-2026)
Table 51. Americas Blood Purification Membrane Revenue by Country (2021-2026) & ($ millions)
Table 52. Americas Blood Purification Membrane Sales by Type (2021-2026) & (K Sqm)
Table 53. Americas Blood Purification Membrane Sales by Application (2021-2026) & (K Sqm)
Table 54. APAC Blood Purification Membrane Sales by Region (2021-2026) & (K Sqm)
Table 55. APAC Blood Purification Membrane Sales Market Share by Region (2021-2026)
Table 56. APAC Blood Purification Membrane Revenue by Region (2021-2026) & ($ millions)
Table 57. APAC Blood Purification Membrane Sales by Type (2021-2026) & (K Sqm)
Table 58. APAC Blood Purification Membrane Sales by Application (2021-2026) & (K Sqm)
Table 59. Europe Blood Purification Membrane Sales by Country (2021-2026) & (K Sqm)
Table 60. Europe Blood Purification Membrane Revenue by Country (2021-2026) & ($ millions)
Table 61. Europe Blood Purification Membrane Sales by Type (2021-2026) & (K Sqm)
Table 62. Europe Blood Purification Membrane Sales by Application (2021-2026) & (K Sqm)
Table 63. Middle East & Africa Blood Purification Membrane Sales by Country (2021-2026) & (K Sqm)
Table 64. Middle East & Africa Blood Purification Membrane Revenue Market Share by Country (2021-2026)
Table 65. Middle East & Africa Blood Purification Membrane Sales by Type (2021-2026) & (K Sqm)
Table 66. Middle East & Africa Blood Purification Membrane Sales by Application (2021-2026) & (K Sqm)
Table 67. Key Market Drivers & Growth Opportunities of Blood Purification Membrane
Table 68. Key Market Challenges & Risks of Blood Purification Membrane
Table 69. Key Industry Trends of Blood Purification Membrane
Table 70. Blood Purification Membrane Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Blood Purification Membrane Distributors List
Table 73. Blood Purification Membrane Customer List
Table 74. Global Blood Purification Membrane Sales Forecast by Region (2027-2032) & (K Sqm)
Table 75. Global Blood Purification Membrane Revenue Forecast by Region (2027-2032) & ($ millions)
Table 76. Americas Blood Purification Membrane Sales Forecast by Country (2027-2032) & (K Sqm)
Table 77. Americas Blood Purification Membrane Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 78. APAC Blood Purification Membrane Sales Forecast by Region (2027-2032) & (K Sqm)
Table 79. APAC Blood Purification Membrane Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 80. Europe Blood Purification Membrane Sales Forecast by Country (2027-2032) & (K Sqm)
Table 81. Europe Blood Purification Membrane Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. Middle East & Africa Blood Purification Membrane Sales Forecast by Country (2027-2032) & (K Sqm)
Table 83. Middle East & Africa Blood Purification Membrane Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. Global Blood Purification Membrane Sales Forecast by Type (2027-2032) & (K Sqm)
Table 85. Global Blood Purification Membrane Revenue Forecast by Type (2027-2032) & ($ millions)
Table 86. Global Blood Purification Membrane Sales Forecast by Application (2027-2032) & (K Sqm)
Table 87. Global Blood Purification Membrane Revenue Forecast by Application (2027-2032) & ($ millions)
Table 88. Fresenius Basic Information, Blood Purification Membrane Manufacturing Base, Sales Area and Its Competitors
Table 89. Fresenius Blood Purification Membrane Product Portfolios and Specifications
Table 90. Fresenius Blood Purification Membrane Sales (K Sqm), Revenue ($ Million), Price (US$/Sq m) and Gross Margin (2021-2026)
Table 91. Fresenius Main Business
Table 92. Fresenius Latest Developments
Table 93. Vantive Health Basic Information, Blood Purification Membrane Manufacturing Base, Sales Area and Its Competitors
Table 94. Vantive Health Blood Purification Membrane Product Portfolios and Specifications
Table 95. Vantive Health Blood Purification Membrane Sales (K Sqm), Revenue ($ Million), Price (US$/Sq m) and Gross Margin (2021-2026)
Table 96. Vantive Health Main Business
Table 97. Vantive Health Latest Developments
Table 98. Nipro Basic Information, Blood Purification Membrane Manufacturing Base, Sales Area and Its Competitors
Table 99. Nipro Blood Purification Membrane Product Portfolios and Specifications
Table 100. Nipro Blood Purification Membrane Sales (K Sqm), Revenue ($ Million), Price (US$/Sq m) and Gross Margin (2021-2026)
Table 101. Nipro Main Business
Table 102. Nipro Latest Developments
Table 103. Asahi Kasei Basic Information, Blood Purification Membrane Manufacturing Base, Sales Area and Its Competitors
Table 104. Asahi Kasei Blood Purification Membrane Product Portfolios and Specifications
Table 105. Asahi Kasei Blood Purification Membrane Sales (K Sqm), Revenue ($ Million), Price (US$/Sq m) and Gross Margin (2021-2026)
Table 106. Asahi Kasei Main Business
Table 107. Asahi Kasei Latest Developments
Table 108. B. Braun Basic Information, Blood Purification Membrane Manufacturing Base, Sales Area and Its Competitors
Table 109. B. Braun Blood Purification Membrane Product Portfolios and Specifications
Table 110. B. Braun Blood Purification Membrane Sales (K Sqm), Revenue ($ Million), Price (US$/Sq m) and Gross Margin (2021-2026)
Table 111. B. Braun Main Business
Table 112. B. Braun Latest Developments
Table 113. Wego Basic Information, Blood Purification Membrane Manufacturing Base, Sales Area and Its Competitors
Table 114. Wego Blood Purification Membrane Product Portfolios and Specifications
Table 115. Wego Blood Purification Membrane Sales (K Sqm), Revenue ($ Million), Price (US$/Sq m) and Gross Margin (2021-2026)
Table 116. Wego Main Business
Table 117. Wego Latest Developments
Table 118. Toray Basic Information, Blood Purification Membrane Manufacturing Base, Sales Area and Its Competitors
Table 119. Toray Blood Purification Membrane Product Portfolios and Specifications
Table 120. Toray Blood Purification Membrane Sales (K Sqm), Revenue ($ Million), Price (US$/Sq m) and Gross Margin (2021-2026)
Table 121. Toray Main Business
Table 122. Toray Latest Developments
Table 123. Toyobo Basic Information, Blood Purification Membrane Manufacturing Base, Sales Area and Its Competitors
Table 124. Toyobo Blood Purification Membrane Product Portfolios and Specifications
Table 125. Toyobo Blood Purification Membrane Sales (K Sqm), Revenue ($ Million), Price (US$/Sq m) and Gross Margin (2021-2026)
Table 126. Toyobo Main Business
Table 127. Toyobo Latest Developments
Table 128. 3M Basic Information, Blood Purification Membrane Manufacturing Base, Sales Area and Its Competitors
Table 129. 3M Blood Purification Membrane Product Portfolios and Specifications
Table 130. 3M Blood Purification Membrane Sales (K Sqm), Revenue ($ Million), Price (US$/Sq m) and Gross Margin (2021-2026)
Table 131. 3M Main Business
Table 132. 3M Latest Developments
Table 133. Kaneka Corporation Basic Information, Blood Purification Membrane Manufacturing Base, Sales Area and Its Competitors
Table 134. Kaneka Corporation Blood Purification Membrane Product Portfolios and Specifications
Table 135. Kaneka Corporation Blood Purification Membrane Sales (K Sqm), Revenue ($ Million), Price (US$/Sq m) and Gross Margin (2021-2026)
Table 136. Kaneka Corporation Main Business
Table 137. Kaneka Corporation Latest Developments
Table 138. Kuraray Basic Information, Blood Purification Membrane Manufacturing Base, Sales Area and Its Competitors
Table 139. Kuraray Blood Purification Membrane Product Portfolios and Specifications
Table 140. Kuraray Blood Purification Membrane Sales (K Sqm), Revenue ($ Million), Price (US$/Sq m) and Gross Margin (2021-2026)
Table 141. Kuraray Main Business
Table 142. Kuraray Latest Developments
Table 143. Mitsubishi Chemical Basic Information, Blood Purification Membrane Manufacturing Base, Sales Area and Its Competitors
Table 144. Mitsubishi Chemical Blood Purification Membrane Product Portfolios and Specifications
Table 145. Mitsubishi Chemical Blood Purification Membrane Sales (K Sqm), Revenue ($ Million), Price (US$/Sq m) and Gross Margin (2021-2026)
Table 146. Mitsubishi Chemical Main Business
Table 147. Mitsubishi Chemical Latest Developments
Table 148. Evonik Industries Basic Information, Blood Purification Membrane Manufacturing Base, Sales Area and Its Competitors
Table 149. Evonik Industries Blood Purification Membrane Product Portfolios and Specifications
Table 150. Evonik Industries Blood Purification Membrane Sales (K Sqm), Revenue ($ Million), Price (US$/Sq m) and Gross Margin (2021-2026)
Table 151. Evonik Industries Main Business
Table 152. Evonik Industries Latest Developments
Table 153. Sartorius Basic Information, Blood Purification Membrane Manufacturing Base, Sales Area and Its Competitors
Table 154. Sartorius Blood Purification Membrane Product Portfolios and Specifications
Table 155. Sartorius Blood Purification Membrane Sales (K Sqm), Revenue ($ Million), Price (US$/Sq m) and Gross Margin (2021-2026)
Table 156. Sartorius Main Business
Table 157. Sartorius Latest Developments
LIST OF FIGURES
Figure 1. Picture of Blood Purification Membrane
Figure 2. Blood Purification Membrane Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Blood Purification Membrane Sales Growth Rate 2021-2032 (K Sqm)
Figure 7. Global Blood Purification Membrane Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Blood Purification Membrane Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Blood Purification Membrane Sales Market Share by Country/Region (2025)
Figure 10. Blood Purification Membrane Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Polysulfone (PSf) Membrane
Figure 12. Product Picture of Polyethersulfone (PES) Membrane
Figure 13. Product Picture of Other
Figure 14. Global Blood Purification Membrane Sales Market Share by Type in 2026
Figure 15. Global Blood Purification Membrane Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of Low-Flux Membrane
Figure 17. Product Picture of Medium-Flux Membrane
Figure 18. Product Picture of High-Flux Membrane
Figure 19. Global Blood Purification Membrane Sales Market Share by Membrane Permeability in 2026
Figure 20. Global Blood Purification Membrane Revenue Market Share by Membrane Permeability (2021-2026)
Figure 21. Product Picture of Dry-Type Membrane
Figure 22. Product Picture of Wet-Type Membrane
Figure 23. Global Blood Purification Membrane Sales Market Share by Membrane Storage Condition in 2026
Figure 24. Global Blood Purification Membrane Revenue Market Share by Membrane Storage Condition (2021-2026)
Figure 25. Blood Purification Membrane Consumed in Hemodialyzer
Figure 26. Global Blood Purification Membrane Market: Hemodialyzer (2021-2026) & (K Sqm)
Figure 27. Blood Purification Membrane Consumed in Hemofilter
Figure 28. Global Blood Purification Membrane Market: Hemofilter (2021-2026) & (K Sqm)
Figure 29. Blood Purification Membrane Consumed in Hemoperfusion Cartridge
Figure 30. Global Blood Purification Membrane Market: Hemoperfusion Cartridge (2021-2026) & (K Sqm)
Figure 31. Blood Purification Membrane Consumed in Other
Figure 32. Global Blood Purification Membrane Market: Other (2021-2026) & (K Sqm)
Figure 33. Global Blood Purification Membrane Sale Market Share by Application (2025)
Figure 34. Global Blood Purification Membrane Revenue Market Share by Application in 2025
Figure 35. Blood Purification Membrane Sales by Company in 2025 (K Sqm)
Figure 36. Global Blood Purification Membrane Sales Market Share by Company in 2025
Figure 37. Blood Purification Membrane Revenue by Company in 2025 ($ millions)
Figure 38. Global Blood Purification Membrane Revenue Market Share by Company in 2025
Figure 39. Global Blood Purification Membrane Sales Market Share by Geographic Region (2021-2026)
Figure 40. Global Blood Purification Membrane Revenue Market Share by Geographic Region in 2025
Figure 41. Americas Blood Purification Membrane Sales 2021-2026 (K Sqm)
Figure 42. Americas Blood Purification Membrane Revenue 2021-2026 ($ millions)
Figure 43. APAC Blood Purification Membrane Sales 2021-2026 (K Sqm)
Figure 44. APAC Blood Purification Membrane Revenue 2021-2026 ($ millions)
Figure 45. Europe Blood Purification Membrane Sales 2021-2026 (K Sqm)
Figure 46. Europe Blood Purification Membrane Revenue 2021-2026 ($ millions)
Figure 47. Middle East & Africa Blood Purification Membrane Sales 2021-2026 (K Sqm)
Figure 48. Middle East & Africa Blood Purification Membrane Revenue 2021-2026 ($ millions)
Figure 49. Americas Blood Purification Membrane Sales Market Share by Country in 2025
Figure 50. Americas Blood Purification Membrane Revenue Market Share by Country (2021-2026)
Figure 51. Americas Blood Purification Membrane Sales Market Share by Type (2021-2026)
Figure 52. Americas Blood Purification Membrane Sales Market Share by Application (2021-2026)
Figure 53. United States Blood Purification Membrane Revenue Growth 2021-2026 ($ millions)
Figure 54. Canada Blood Purification Membrane Revenue Growth 2021-2026 ($ millions)
Figure 55. Mexico Blood Purification Membrane Revenue Growth 2021-2026 ($ millions)
Figure 56. Brazil Blood Purification Membrane Revenue Growth 2021-2026 ($ millions)
Figure 57. APAC Blood Purification Membrane Sales Market Share by Region in 2025
Figure 58. APAC Blood Purification Membrane Revenue Market Share by Region (2021-2026)
Figure 59. APAC Blood Purification Membrane Sales Market Share by Type (2021-2026)
Figure 60. APAC Blood Purification Membrane Sales Market Share by Application (2021-2026)
Figure 61. China Blood Purification Membrane Revenue Growth 2021-2026 ($ millions)
Figure 62. Japan Blood Purification Membrane Revenue Growth 2021-2026 ($ millions)
Figure 63. South Korea Blood Purification Membrane Revenue Growth 2021-2026 ($ millions)
Figure 64. Southeast Asia Blood Purification Membrane Revenue Growth 2021-2026 ($ millions)
Figure 65. India Blood Purification Membrane Revenue Growth 2021-2026 ($ millions)
Figure 66. Australia Blood Purification Membrane Revenue Growth 2021-2026 ($ millions)
Figure 67. China Taiwan Blood Purification Membrane Revenue Growth 2021-2026 ($ millions)
Figure 68. Europe Blood Purification Membrane Sales Market Share by Country in 2025
Figure 69. Europe Blood Purification Membrane Revenue Market Share by Country (2021-2026)
Figure 70. Europe Blood Purification Membrane Sales Market Share by Type (2021-2026)
Figure 71. Europe Blood Purification Membrane Sales Market Share by Application (2021-2026)
Figure 72. Germany Blood Purification Membrane Revenue Growth 2021-2026 ($ millions)
Figure 73. France Blood Purification Membrane Revenue Growth 2021-2026 ($ millions)
Figure 74. UK Blood Purification Membrane Revenue Growth 2021-2026 ($ millions)
Figure 75. Italy Blood Purification Membrane Revenue Growth 2021-2026 ($ millions)
Figure 76. Russia Blood Purification Membrane Revenue Growth 2021-2026 ($ millions)
Figure 77. Middle East & Africa Blood Purification Membrane Sales Market Share by Country (2021-2026)
Figure 78. Middle East & Africa Blood Purification Membrane Sales Market Share by Type (2021-2026)
Figure 79. Middle East & Africa Blood Purification Membrane Sales Market Share by Application (2021-2026)
Figure 80. Egypt Blood Purification Membrane Revenue Growth 2021-2026 ($ millions)
Figure 81. South Africa Blood Purification Membrane Revenue Growth 2021-2026 ($ millions)
Figure 82. Israel Blood Purification Membrane Revenue Growth 2021-2026 ($ millions)
Figure 83. Turkey Blood Purification Membrane Revenue Growth 2021-2026 ($ millions)
Figure 84. GCC Countries Blood Purification Membrane Revenue Growth 2021-2026 ($ millions)
Figure 85. Manufacturing Cost Structure Analysis of Blood Purification Membrane in 2026
Figure 86. Manufacturing Process Analysis of Blood Purification Membrane
Figure 87. Industry Chain Structure of Blood Purification Membrane
Figure 88. Channels of Distribution
Figure 89. Global Blood Purification Membrane Sales Market Forecast by Region (2027-2032)
Figure 90. Global Blood Purification Membrane Revenue Market Share Forecast by Region (2027-2032)
Figure 91. Global Blood Purification Membrane Sales Market Share Forecast by Type (2027-2032)
Figure 92. Global Blood Purification Membrane Revenue Market Share Forecast by Type (2027-2032)
Figure 93. Global Blood Purification Membrane Sales Market Share Forecast by Application (2027-2032)
Figure 94. Global Blood Purification Membrane Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Blood Purification Membrane
Figure 2. Blood Purification Membrane Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Blood Purification Membrane Sales Growth Rate 2021-2032 (K Sqm)
Figure 7. Global Blood Purification Membrane Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Blood Purification Membrane Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Blood Purification Membrane Sales Market Share by Country/Region (2025)
Figure 10. Blood Purification Membrane Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Polysulfone (PSf) Membrane
Figure 12. Product Picture of Polyethersulfone (PES) Membrane
Figure 13. Product Picture of Other
Figure 14. Global Blood Purification Membrane Sales Market Share by Type in 2026
Figure 15. Global Blood Purification Membrane Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of Low-Flux Membrane
Figure 17. Product Picture of Medium-Flux Membrane
Figure 18. Product Picture of High-Flux Membrane
Figure 19. Global Blood Purification Membrane Sales Market Share by Membrane Permeability in 2026
Figure 20. Global Blood Purification Membrane Revenue Market Share by Membrane Permeability (2021-2026)
Figure 21. Product Picture of Dry-Type Membrane
Figure 22. Product Picture of Wet-Type Membrane
Figure 23. Global Blood Purification Membrane Sales Market Share by Membrane Storage Condition in 2026
Figure 24. Global Blood Purification Membrane Revenue Market Share by Membrane Storage Condition (2021-2026)
Figure 25. Blood Purification Membrane Consumed in Hemodialyzer
Figure 26. Global Blood Purification Membrane Market: Hemodialyzer (2021-2026) & (K Sqm)
Figure 27. Blood Purification Membrane Consumed in Hemofilter
Figure 28. Global Blood Purification Membrane Market: Hemofilter (2021-2026) & (K Sqm)
Figure 29. Blood Purification Membrane Consumed in Hemoperfusion Cartridge
Figure 30. Global Blood Purification Membrane Market: Hemoperfusion Cartridge (2021-2026) & (K Sqm)
Figure 31. Blood Purification Membrane Consumed in Other
Figure 32. Global Blood Purification Membrane Market: Other (2021-2026) & (K Sqm)
Figure 33. Global Blood Purification Membrane Sale Market Share by Application (2025)
Figure 34. Global Blood Purification Membrane Revenue Market Share by Application in 2025
Figure 35. Blood Purification Membrane Sales by Company in 2025 (K Sqm)
Figure 36. Global Blood Purification Membrane Sales Market Share by Company in 2025
Figure 37. Blood Purification Membrane Revenue by Company in 2025 ($ millions)
Figure 38. Global Blood Purification Membrane Revenue Market Share by Company in 2025
Figure 39. Global Blood Purification Membrane Sales Market Share by Geographic Region (2021-2026)
Figure 40. Global Blood Purification Membrane Revenue Market Share by Geographic Region in 2025
Figure 41. Americas Blood Purification Membrane Sales 2021-2026 (K Sqm)
Figure 42. Americas Blood Purification Membrane Revenue 2021-2026 ($ millions)
Figure 43. APAC Blood Purification Membrane Sales 2021-2026 (K Sqm)
Figure 44. APAC Blood Purification Membrane Revenue 2021-2026 ($ millions)
Figure 45. Europe Blood Purification Membrane Sales 2021-2026 (K Sqm)
Figure 46. Europe Blood Purification Membrane Revenue 2021-2026 ($ millions)
Figure 47. Middle East & Africa Blood Purification Membrane Sales 2021-2026 (K Sqm)
Figure 48. Middle East & Africa Blood Purification Membrane Revenue 2021-2026 ($ millions)
Figure 49. Americas Blood Purification Membrane Sales Market Share by Country in 2025
Figure 50. Americas Blood Purification Membrane Revenue Market Share by Country (2021-2026)
Figure 51. Americas Blood Purification Membrane Sales Market Share by Type (2021-2026)
Figure 52. Americas Blood Purification Membrane Sales Market Share by Application (2021-2026)
Figure 53. United States Blood Purification Membrane Revenue Growth 2021-2026 ($ millions)
Figure 54. Canada Blood Purification Membrane Revenue Growth 2021-2026 ($ millions)
Figure 55. Mexico Blood Purification Membrane Revenue Growth 2021-2026 ($ millions)
Figure 56. Brazil Blood Purification Membrane Revenue Growth 2021-2026 ($ millions)
Figure 57. APAC Blood Purification Membrane Sales Market Share by Region in 2025
Figure 58. APAC Blood Purification Membrane Revenue Market Share by Region (2021-2026)
Figure 59. APAC Blood Purification Membrane Sales Market Share by Type (2021-2026)
Figure 60. APAC Blood Purification Membrane Sales Market Share by Application (2021-2026)
Figure 61. China Blood Purification Membrane Revenue Growth 2021-2026 ($ millions)
Figure 62. Japan Blood Purification Membrane Revenue Growth 2021-2026 ($ millions)
Figure 63. South Korea Blood Purification Membrane Revenue Growth 2021-2026 ($ millions)
Figure 64. Southeast Asia Blood Purification Membrane Revenue Growth 2021-2026 ($ millions)
Figure 65. India Blood Purification Membrane Revenue Growth 2021-2026 ($ millions)
Figure 66. Australia Blood Purification Membrane Revenue Growth 2021-2026 ($ millions)
Figure 67. China Taiwan Blood Purification Membrane Revenue Growth 2021-2026 ($ millions)
Figure 68. Europe Blood Purification Membrane Sales Market Share by Country in 2025
Figure 69. Europe Blood Purification Membrane Revenue Market Share by Country (2021-2026)
Figure 70. Europe Blood Purification Membrane Sales Market Share by Type (2021-2026)
Figure 71. Europe Blood Purification Membrane Sales Market Share by Application (2021-2026)
Figure 72. Germany Blood Purification Membrane Revenue Growth 2021-2026 ($ millions)
Figure 73. France Blood Purification Membrane Revenue Growth 2021-2026 ($ millions)
Figure 74. UK Blood Purification Membrane Revenue Growth 2021-2026 ($ millions)
Figure 75. Italy Blood Purification Membrane Revenue Growth 2021-2026 ($ millions)
Figure 76. Russia Blood Purification Membrane Revenue Growth 2021-2026 ($ millions)
Figure 77. Middle East & Africa Blood Purification Membrane Sales Market Share by Country (2021-2026)
Figure 78. Middle East & Africa Blood Purification Membrane Sales Market Share by Type (2021-2026)
Figure 79. Middle East & Africa Blood Purification Membrane Sales Market Share by Application (2021-2026)
Figure 80. Egypt Blood Purification Membrane Revenue Growth 2021-2026 ($ millions)
Figure 81. South Africa Blood Purification Membrane Revenue Growth 2021-2026 ($ millions)
Figure 82. Israel Blood Purification Membrane Revenue Growth 2021-2026 ($ millions)
Figure 83. Turkey Blood Purification Membrane Revenue Growth 2021-2026 ($ millions)
Figure 84. GCC Countries Blood Purification Membrane Revenue Growth 2021-2026 ($ millions)
Figure 85. Manufacturing Cost Structure Analysis of Blood Purification Membrane in 2026
Figure 86. Manufacturing Process Analysis of Blood Purification Membrane
Figure 87. Industry Chain Structure of Blood Purification Membrane
Figure 88. Channels of Distribution
Figure 89. Global Blood Purification Membrane Sales Market Forecast by Region (2027-2032)
Figure 90. Global Blood Purification Membrane Revenue Market Share Forecast by Region (2027-2032)
Figure 91. Global Blood Purification Membrane Sales Market Share Forecast by Type (2027-2032)
Figure 92. Global Blood Purification Membrane Revenue Market Share Forecast by Type (2027-2032)
Figure 93. Global Blood Purification Membrane Sales Market Share Forecast by Application (2027-2032)
Figure 94. Global Blood Purification Membrane Revenue Market Share Forecast by Application (2027-2032)
